These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 15725805)

  • 1. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
    Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
    Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
    Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
    [No Abstract]   [Full Text] [Related]  

  • 3. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
    Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
    Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas.
    Xue Y; Vanoli A; Balci S; Reid MM; Saka B; Bagci P; Memis B; Choi H; Ohike N; Tajiri T; Muraki T; Quigley B; El-Rayes BF; Shaib W; Kooby D; Sarmiento J; Maithel SK; Knight JH; Goodman M; Krasinskas AM; Adsay V
    Mod Pathol; 2017 Feb; 30(2):255-266. PubMed ID: 27739441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical Predictors for Intestinal and Pancreatobiliary Types of Adenocarcinoma of The Ampulla of Vater.
    da Silveira Santos JPL; Machado CJ; Junior EP; Rodrigues JBSR; Vidigal PT; Resende V
    J Gastrointest Surg; 2018 Jul; 22(7):1171-1178. PubMed ID: 29736668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.
    Sanada Y; Yoshida K; Konishi K; Oeda M; Ohara M; Tsutani Y
    Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
    Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
    de Paiva Haddad LB; Patzina RA; Penteado S; Montagnini AL; da Cunha JE; Machado MC; Jukemura J
    J Gastrointest Surg; 2010 Apr; 14(4):719-28. PubMed ID: 20107918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater.
    Ang DC; Shia J; Tang LH; Katabi N; Klimstra DS
    Am J Surg Pathol; 2014 Oct; 38(10):1371-9. PubMed ID: 24832159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas.
    Adsay NV; Merati K; Basturk O; Iacobuzio-Donahue C; Levi E; Cheng JD; Sarkar FH; Hruban RH; Klimstra DS
    Am J Surg Pathol; 2004 Jul; 28(7):839-48. PubMed ID: 15223952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical Classification of Ampullary Carcinomas: Critical Reappraisal Fails to Confirm Prognostic Relevance for Recently Proposed Panels, and Highlights MUC5AC as a Strong Prognosticator.
    Xue Y; Reid MD; Balci S; Quigley B; Muraki T; Memis B; Xia J; Hacihasanoglu E; Bedolla G; Pehlivanoglu B; Kim GE; Tajiri T; Ohike N; Aneja R; Krasinskas AM; Adsay V
    Am J Surg Pathol; 2017 Jul; 41(7):865-876. PubMed ID: 28505002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis.
    Ishikawa A; Sasaki M; Ohira S; Ohta T; Oda K; Nimura Y; Chen MF; Jan YY; Yeh TS; Nakanuma Y
    Lab Invest; 2004 May; 84(5):629-38. PubMed ID: 15048136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of MUC1, MUC2 and CK17 expression patterns for diagnosis of pancreatobiliary arcinoma.
    Yang HS; Tamayo R; Almonte M; Horten B; DaSilva M; Gangi M; Vazquez E; Joseph D; Okamoto P; Scholl T
    Biotech Histochem; 2012 Feb; 87(2):126-32. PubMed ID: 21438791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases.
    Ohike N; Kim GE; Tajiri T; Krasinskas A; Basturk O; Coban I; Bandyopadhyay S; Morohoshi T; Goodman M; Kooby DA; Sarmiento JM; Adsay NV
    Am J Surg Pathol; 2010 Dec; 34(12):1731-48. PubMed ID: 21084962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucins in neoplasms of pancreas, ampulla of Vater and biliary system.
    Moschovis D; Bamias G; Delladetsima I
    World J Gastrointest Oncol; 2016 Oct; 8(10):725-734. PubMed ID: 27795812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma.
    Lok T; Chen L; Lin F; Wang HL
    Hum Pathol; 2014 Feb; 45(2):394-400. PubMed ID: 24439226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold.
    Goldstein NS; Bassi D
    Am J Clin Pathol; 2001 May; 115(5):695-702. PubMed ID: 11345833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups.
    Leo JM; Kalloger SE; Peixoto RD; Gale NS; Webber DL; Owen DA; Renouf D; Schaeffer DF
    J Clin Pathol; 2016 May; 69(5):431-9. PubMed ID: 26500334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
    Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
    J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.